Walleye Capital
ZLAB icon

Walleye Capital’s Zai Lab ZLAB Stock Holding History

Walleye Capital’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-94,678
Closed -$1.78M – 5235
2026
Q1 		$1.78M Sell
94,678
-278,721
-75% -$5.17M 0.01% 1562
2025
Q4 		$6.59M Buy
+373,399
New +$8.74M 0.02% 938
2025
Q3 		– Sell
-13,949
Closed -$488K – 5240
2025
Q2 		$488K Sell
13,949
-8,327
-37% -$274K ﹤0.01% 2653
2025
Q1 		$805K Buy
22,276
+21,838
+4,986% +$672K ﹤0.01% 2154
2024
Q4 		$11.5K Sell
438
-3,010
-87% -$83.6K ﹤0.01% 4569
2024
Q3 		$83.2K Sell
3,448
-18,869
-85% -$357K ﹤0.01% 4471
2024
Q2 		$387K Buy
22,317
+904
+4% +$15.9K ﹤0.01% 3731
2024
Q1 		$343K Buy
+21,413
New +$451K ﹤0.01% 3532

Other funds holding ZLAB

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Walleye Capital's ZLAB Position: Q2 2026 in Review

Walleye Capital sold out of Zai Lab (ZLAB) in Q2 2026, closing a stake of 94,678 shares — an estimated $1.78M sold.

Walleye Capital first reported a position in ZLAB in Q1 2024 and held it in 8 quarters. The position peaked at $6.59M in Q4 2025. 92 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

  • Walleye Capital reported no remaining Zai Lab position as of Q2 2026 after selling out during the quarter.
  • Walleye Capital sold 94,678 Zai Lab shares in Q2 2026, an estimated $1.78M.
  • Walleye Capital first reported a position in Zai Lab in Q1 2024 and held it in 8 quarters.
  • Walleye Capital's Zai Lab position peaked at $6.59M in Q4 2025.
  • 92 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.